Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Thorpe

Showing results (341-350 of 354) with videos related to

Pageof 36
Sort By:
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022Jane Hitti, Lisa M Frenkel, Alice M Stek, et al.
HIV Medicine|March 28, 2008
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokineticsE V Capparelli, F Aweeka, J Hitti, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021D R Snydman, L A McDermott, C M Thorpe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2021
Pharmacokinetics and ADME Characterization of Intravenous and Oral [<sup>14</sup>C]-Linerixibat in Healthy Male VolunteersMaciej J Zamek-Gliszczynski, David Kenworthy, David A Bershas, et al.
Journal of Opioid Management|January 11, 2021
Identifying sociodemographic profiles of veterans at risk for high-dose opioid prescribing using classification and regression treesJacob S Lipkin, Joshua M Thorpe, Walid F Gellad, et al.
Annals of Internal Medicine|March 12, 2019
Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control StudyPatience Moyo, Xinhua Zhao, Carolyn T Thorpe, et al.
Research in Social & Administrative Pharmacy : RSAP|November 3, 2018
Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among VeteransPatience Moyo, Xinhua Zhao, Carolyn T Thorpe, et al.
Journal of General Internal Medicine|March 10, 2018
Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative StudyThomas R Radomski, Felicia R Bixler, Susan L Zickmund, et al.
Pageof 36

Showing results (341-350 of 354) with videos related to

Sort By:
Pageof 36
Diabetes|June 29, 2004
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisJosephine M Forbes, Louis Teo Loon Yee, Vicki Thallas, et al.
Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Maternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022Jane Hitti, Lisa M Frenkel, Alice M Stek, et al.
HIV Medicine|March 28, 2008
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokineticsE V Capparelli, F Aweeka, J Hitti, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2023
A US-based national surveillance study for the susceptibility and epidemiology of <i>Clostridioides difficile</i> isolates with special reference to ridinilazole: 2020-2021D R Snydman, L A McDermott, C M Thorpe, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 2021
Pharmacokinetics and ADME Characterization of Intravenous and Oral [<sup>14</sup>C]-Linerixibat in Healthy Male VolunteersMaciej J Zamek-Gliszczynski, David Kenworthy, David A Bershas, et al.
Journal of Opioid Management|January 11, 2021
Identifying sociodemographic profiles of veterans at risk for high-dose opioid prescribing using classification and regression treesJacob S Lipkin, Joshua M Thorpe, Walid F Gellad, et al.
Annals of Internal Medicine|March 12, 2019
Dual Receipt of Prescription Opioids From the Department of Veterans Affairs and Medicare Part D and Prescription Opioid Overdose Death Among Veterans: A Nested Case-Control StudyPatience Moyo, Xinhua Zhao, Carolyn T Thorpe, et al.
Research in Social & Administrative Pharmacy : RSAP|November 3, 2018
Patterns of opioid prescriptions received prior to unintentional prescription opioid overdose death among VeteransPatience Moyo, Xinhua Zhao, Carolyn T Thorpe, et al.
Journal of General Internal Medicine|March 10, 2018
Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative StudyThomas R Radomski, Felicia R Bixler, Susan L Zickmund, et al.
Pageof 36